EU5 rheumatologits rate Rituxan and Benlysta for Lupus The Pharma Letter Rheumatologists in the top European nations ( EU5) countries (France, Germany, Italy, Spain, UK) give Roche (ROG: SIX)/Genentech/Biogen Idec's (Nasdaq: BIIB) Rituxan (rituximab) and GlaxoSmithKline (LSE: GSK)/Human Genome Sciences' Benlysta ... |
